ORBIMED ADVISORS LLC

Holdings History for C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 883,534 shares
Security Ownership %: 1%

Shares, Excluding Options vs Price

Value, Excluding Options

OrbiMed Capital LLC ownership in C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

17 Feb 2026 - OrbiMed Capital LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 883,534 shares of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC). This represents 1% ownership of the company. In their previous filing dated 14 Nov 2025, ORBIMED ADVISORS LLC had reported owning 3,568,346 shares, indicating a decrease of +75%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
OrbiMed Capital LLC	1%	-80%	$1,687,550	883,534	-2,684,812	-75%	$1.91	13G/A	31 Dec 2025	17 Feb 2026, 18:18
OrbiMed Capital LLC	5%	-23%	$7,921,728	3,568,346	-1,087,254	-23%	$2.22	13G/A	30 Sep 2025	14 Nov 2025, 18:08
OrbiMed Capital LLC	6.6%		$7,169,624	4,655,600			$1.54	13G/A	31 Mar 2025	15 May 2025, 20:09

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.06%	-0.16%	$2,683,363	1,404,902	-3,830,244	-73%	$1.91	Q4 2025
30 Sep 2025		0.28%	-0.08%	$11,622,024	5,235,146	-1,595,154	-23%	$2.22	Q3 2025
30 Jun 2025		0.25%	0%	$9,767,329	6,830,300	0		$1.43	Q2 2025
31 Mar 2025		0.26%	+0.09%	$10,928,480	6,830,300	+2,452,400		$1.60	Q1 2025
31 Mar 2025	call		-1.2%	$0	0	-150,000	-100%	$2.23	Q1 2025
31 Dec 2024		0.33%	0%	$15,760,440	4,377,900	0		$3.60	Q4 2024
31 Dec 2024	call	1.2%	0%	$540,000	150,000	0		$3.60	Q4 2024
30 Sep 2024		0.46%	+0.3%	$24,954,030	4,377,900	+2,864,842	+189%	$5.70	Q3 2024
30 Sep 2024	call	2.2%	+2.2%	$855,000	150,000	+150,000	NEW	$5.70	Q3 2024
30 Jun 2024		0.15%	+0.14%	$6,990,328	1,513,058	+1,513,058	NEW	$4.62	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.